Treatment of deafness associated with cochlear implant

摘要

In this specificationBefore undergoing internal ear surgeryWhile undergoing surgeryAnd / or after surgeryEffective quantity4 - disulfonyl α－ Phenyl tertiary butyl nitrone4 - dspbn) or its medically acceptable saltIn an object requiring cochlear implant, including administering N-acetylcysteine (NAC) or its medically acceptable saMethods for reducing the adverse effects of the internal ear surgery are disclosed.Diagram